Investors Results

10Branch, LLC combines capital with an operationally proven approach to help companies find deliberate growth.

111° West Capital is an investment fund focused on high growth, digital health companies

4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies

500 Global Vietnam is a US$14 million fund aiming to make ~80 investments into Vietnam-connected startups, i.e., startups built by Vietnamese talent and/or

7wire ventures focuses on investing in early and growth-stage companies focused on healthcare IT, digital healtcare and mobile health.

AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.

AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.

ABRY Partners is an equity firm focused on investments in media.

The Acadiana Angels are a growing team of accredited investors from South Louisiana who are looking to find and invest in the next big startup. Join us as

Access Ventures invest across asset classes, with focus on SaaS, operating orgs, and real estate.

Fund AgTech entrepreneurs and help them towards success through mentorship and financial support.

Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.

We are a fast-moving, intensely curious early-stage investment group. We seek exceptional, inspired founders from around the world who will set the course

What unites a global investment and research firm? Connections to our clients, our culture, one another and the communities we serve. This cohesiveness fosters

Alpha Sigma Capital is a hedge fund management firm investing in technology companies that are leveraging blockchain technology.

Arboretum Ventures is a venture capital firm specializing in the healthcare sector. Founded in 2002 and headquartered in Ann Arbor, Michigan, we have raised

Over 30 years, ARCH has backed disruptive science with as little as $50K and as much as $150M, per company. We are not interested in following the crowd.

At One Ventures finds, funds, and grows teams to catalyze a world where humanity is a net positive to nature. We back early-stage (Seed, Series A) companies

Atlas Venture, a leading early stage venture capital and venture creation firm investing in biotech innovation, today announced the closing of its second

Backend Capital is an early stage fund focused on investing in brilliant engineers.

Band of Angels is an investment firm that offers financial and advisory services to start-up companies.

Founded in 1997, Bay City Capital LLC is a life sciences investment firm with a global diversified strategy ranging from seed stage to public companies, and

BELLE Capital USA, LP is an early stage angel fund focused on building great companies in underserved capital markets across the USA. We look for capital

We believe in the primacy of great markets and great people all aligned with one mission. We invest in extraordinary people and cutting edge biotech and medical

Cells are the engine of the next decade. The era of Creative Bioscience is here. Biology, chemistry and technology are converging, challenging the traditional

Breakthrough Energy is dedicated to helping humanity avoid a climate disaster. Through investment vehicles, philanthropic programs, policy advocacy, and other

Builders believes it takes more than great technology to fix an antiquated industry. To truly make impactful change, Builders backs entrepreneurs who combine

C5 is a specialist technology investment firm that invests in cybersecurity, cloud infrastructure, data analytics, energy and space.

Canapi seeks to invest in early to growth-stage fintech companies offering disruptive alternatives to outdated business models and technologies. Our leaders

Some call it deep tech. We think of it as near frontier. We believe science-forward companies are our best shot at improving billions of lives and stewarding

Founded in 2009, the Capital Angel Network (CAN) has been investing in startups in the National Capital Region for almost a decade. Since its inception CAN

They partner with startups (tech and non-tech) with the potential to grow quickly and sustainably.

Cardinal Partners has been investing in disruptive healthcare technology-enabled services and life sciences companies providing top quartile returns. We position

Carolina Angel Network provides an angel investing platform and co-investment fund that leverages the UNC alumni network.

The Chemical Angel Network provides a forum to present business proposals to a network of highly qualified and experienced accredited investors who are interested

Cherrystone Angel Group invests in early stage companies, primarily in New England across many industry verticals. Our group is made up of qualified investors

Civilization Ventures leverages an extensive network of world-class scientists and clinicians (including half a dozen MDs and PhDs), as well as accomplished

Connectivity Ventures Fund is an early stage fund helping extraordinary founders build exceptional companies. We believe in the power of curious and committed

CRV is a venture capital firm that invests in early-stage tech startups. Since 1970, the firm has invested in more than 500 startups at their most crucial